The Regulatory Updates section monitors pharma and drug across India's pharmaceutical sector. Significant developments around approval continue to draw attention from regulators, investors, and industry professionals, reflecting the dynamic pace of change in this space.
Recent coverage has drawn from The Manila Times, EquityBulls, and 데일리팜, among other publications. This section is updated as new stories emerge, ensuring readers have access to the most current information shaping this part of the pharmaceutical landscape.
For authoritative reference, CDSCO Drug Approvals and US FDA Drug Approvals publish official guidance and regulatory documentation relevant to these topics. Peer-reviewed research and clinical data can be accessed through WHO Prequalification Programme.
Showing 30 articles
-
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity
New data from Phase 2 ZUPREME-1 trial at the American Diabetes Association 2026 Scientific Sessions further support potential of petrelintide to redefine the weight management experience for people living with overweight and obesity The Manila Times
-
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg
Aurobindo Pharma receives final US FDA approval for Tofacitinib Tablets, 5 mg and 10 mg EquityBulls
-
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea 데일리팜
-
Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides
Alabama Board of Medical Examiners Issues Warning of Non-FDA-Approved Peptides Drug Topics
-
Medicus Pharma advances SkinJect toward registrational trial for rare Gorlin Syndrome
Medicus Pharma advances SkinJect toward registrational trial for rare Gorlin Syndrome Proactive financial news
-
Newspoint: Khorakiwala’s antibiotic bet
Newspoint: Khorakiwala’s antibiotic bet financialexpress.com
-
Breaking !! CMS Hemp Program Appeal Filed in Federal Appellate Court
Breaking !! CMS Hemp Program Appeal Filed in Federal Appellate Court Newswire.com
-
4 Biotech Stocks Investors Should Watch in 2026
4 Biotech Stocks Investors Should Watch in 2026 TradingView
-
Q&A: Why Pharma Supply Chains Are Turning to AI
Q&A: Why Pharma Supply Chains Are Turning to AI Pharmaceutical Commerce
-
FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma?
FAQ: What Does the Medicare GLP-1 Bridge Mean for Pharma? Pharmaceutical Commerce
-
Alembic Pharma Bags USFDA Approval for Generic Haldol Tablets, Targets USD 27 Million Market
Alembic Pharma Bags USFDA Approval for Generic Haldol Tablets, Targets USD 27 Million Market Medical Dialogues
-
Mezzion Pharma Completes FUEL-2 Phase 3 Regulatory Milestone
Mezzion Pharma Completes FUEL-2 Phase 3 Regulatory Milestone PR Newswire
-
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea
데일리팜코리아, 데일리팜 영문뉴스, dailypharmkorea 데일리팜
-
Shionogi’s New U.S. And China Drug Approvals Shift Growth Outlook
Shionogi’s New U.S. And China Drug Approvals Shift Growth Outlook simplywall.st
-
Why decades-old medicines can still create new insurance risks
Why decades-old medicines can still create new insurance risks Insurance Business
-
FDA approves third interchangeable insulin glargine biosimilar Langlara
FDA approves third interchangeable insulin glargine biosimilar Langlara Generics and Biosimilars Initiative
-
Aurobindo Pharma Gets USFDA Nod For Arthritis Drug With $494 Million Market Potential
Aurobindo Pharma Gets USFDA Nod For Arthritis Drug With $494 Million Market Potential Trade Brains
-
Secretary for Health concludes visit to Fujian (with photos)
Secretary for Health concludes visit to Fujian (with photos) info.gov.hk
-
Alembic Pharmaceuticals in Focus After Receiving USFDA Approval For Drug With $27 Million Market Opportunity
Alembic Pharmaceuticals in Focus After Receiving USFDA Approval For Drug With $27 Million Market Opportunity Trade Brains
-
DH invites representatives from GBA Center for Drug Evaluation and Inspection of National Medical Products Administration to brief local pharmaceutical industry on latest developments in drug regulation and registration evaluation in Chinese Mainland (with
DH invites representatives from GBA Center for Drug Evaluation and Inspection of National Medical Products Administration to brief local pharmaceutical industry on latest developments in drug regulation and registration evaluation in Chinese Mainland (with info.gov.hk
-
Hikma v. Amarin: Supreme Court Clarifies Patent Inducement Liability
Hikma v. Amarin: Supreme Court Clarifies Patent Inducement Liability Lawyer Monthly
-
United States Pharmaceutical Market Set to Reach US$ 979.25 Billion by 2033 as Innovation, Aging Population, and Specialty Drugs Drive Growth
United States Pharmaceutical Market Set to Reach US$ 979.25 Billion by 2033 as Innovation, Aging Population, and Specialty Drugs Drive Growth vocal.media
-
Flerie’s portfolio company Xspray Pharma receives CRL from FDA for Nilopki™
Flerie’s portfolio company Xspray Pharma receives CRL from FDA for Nilopki™ TradingView
-
Aurobindo Pharma Secures USFDA Approval for Tofacitinib Tablets
Aurobindo Pharma Secures USFDA Approval for Tofacitinib Tablets Siliconindia
-
Alembic Pharma Gets USFDA Approval For Haloperidol Tablets; Shares Rise
Alembic Pharma Gets USFDA Approval For Haloperidol Tablets; Shares Rise HDFC Sky
-
Madras High Court Holds Chennai API Maker's Export Of Diabetes Drug Vildagliptin To Egypt Infringed...
Madras High Court Holds Chennai API Maker's Export Of Diabetes Drug Vildagliptin To Egypt Infringed... LiveLawBiz
-
Hyderabad-based Aurobindo Pharma gets US FDA nod for arthritis and colitis drug, eyes $494 million market
Hyderabad-based Aurobindo Pharma gets US FDA nod for arthritis and colitis drug, eyes $494 million market financialexpress.com
-
Kenya Poised as Regional Pharmaceutical Hub but Barriers Remain
Kenya Poised as Regional Pharmaceutical Hub but Barriers Remain Science Africa
-
Aurobindo Pharma officials to attend UBS virtual investor meet
Aurobindo Pharma officials to attend UBS virtual investor meet scanx.trade
-
Lupin Receives Approval from U.S. FDA for RanluspecTM (ranibizumab) Injection - Lupin | Press Release
Lupin Receives Approval from U.S. FDA for RanluspecTM (ranibizumab) Injection - Lupin | Press Release lupin.com